Spain’s Grifols has agreed to work with the U.S. Food and Drug Administration and other agencies to gather plasma from patients who have recovered from COVID-19 and test potential therapies for the disease, the pharmaceutical firm said on Wednesday…
USA – FDA, Grifols to develop plasma therapeutics for COVID-19
